---
figid: PMC7991804__fonc-11-617937-g0002
figlink: pmc/articles/PMC7991804/figure/F2/
number: F2
caption: 'An overview of mechanisms of GC resistance in ALL and pharmacological strategies
  to overcome it. (Left) GC resistance in ALL is related to different genetic aberrations
  (see references in the text), which cause () upregulation of Notch, IL7R, Flt3,
  and MEK/ERK pathways, with a consequent upregulation of PI3K/Akt/mTOR and Glut1
  and acceleration of cellular growth and metabolism; () downregulation of the proapoptotic
  proteins (BIM) and upregulation of the antiapoptotic proteins (Bcl-2, Bcl-XL, Mcl-1,
  and A1), with a consequent apoptosis inhibition; () overexpression of MDR proteins.
  A hypermethylation of BCL2L11 results in its inaccessibility to the transcriptional
  upregulation by a GR (left and upper right). The mTOR activation causes upregulation
  of glycolysis (middle right) and OXPHOS, and inhibition of autophagy. Upregulation
  of glycolysis can be opposed by the inhibition of hexokinase (HK), the first glycolytic
  enzyme. Ca2+signaling is involved in the NFAT activation via the Ca2+-dependent
  dephosphorylation by calcineurin (CN). A sustained Ca2+ signal is achieved due to
  a repression of the recycling of ORAI (main Ca2+ influx component) and Kv1.3 (mediating
  K+ efflux, which supports Ca2+ influx) proteins via the PI3K/SGK1 pathway (lower
  right). The above mechanisms can be opposed by inhibitors of FLT3, IL7R, γ secretase,
  Akt1/2, P-gp, glycolysis, PI3K/AKT, SGK, and mTOR as well as by BH-3 mimetics and
  hypomethylating agents. A possible toxicity of PI3R/AKT/mTOR inhibitors as well
  as of glycolysis/ hexokinase (HK) inhibitors 3-bromopyruvate (3-BP), 2-deoxy-D-glucose
  (2-DG), 1-(2,4-dichlorobenzyl)-1H-indazol-3 carboxylic acid) (lonidamine, LND) needs
  to be considered. Some re-purposed drugs may improve antileukemic protocols: ()
  TGC, which targets mitochondria and OXPHOS; () CBD, which targets mitochondria,
  causes the MTP-driven necrosis and inhibits P-gp; () TAM, which targets mitochondria,
  induces autophagy, inhibits P-gp and enhances the sensitivity to GCs; () anthelmintics,
  which inhibit GLUT1 and Hes1. For more details please consult the text.'
pmcid: PMC7991804
papertitle: 'Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia:
  Repurposed Drugs Can Improve the Protocol.'
reftext: Miguel Olivas-Aguirre, et al. Front Oncol. 2021;11:617937.
pmc_ranked_result_index: '118671'
pathway_score: 0.938592
filename: fonc-11-617937-g0002.jpg
figtitle: An overview of mechanisms of GC resistance in ALL and pharmacological strategies
  to overcome it
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7991804__fonc-11-617937-g0002.html
  '@type': Dataset
  description: 'An overview of mechanisms of GC resistance in ALL and pharmacological
    strategies to overcome it. (Left) GC resistance in ALL is related to different
    genetic aberrations (see references in the text), which cause () upregulation
    of Notch, IL7R, Flt3, and MEK/ERK pathways, with a consequent upregulation of
    PI3K/Akt/mTOR and Glut1 and acceleration of cellular growth and metabolism; ()
    downregulation of the proapoptotic proteins (BIM) and upregulation of the antiapoptotic
    proteins (Bcl-2, Bcl-XL, Mcl-1, and A1), with a consequent apoptosis inhibition;
    () overexpression of MDR proteins. A hypermethylation of BCL2L11 results in its
    inaccessibility to the transcriptional upregulation by a GR (left and upper right).
    The mTOR activation causes upregulation of glycolysis (middle right) and OXPHOS,
    and inhibition of autophagy. Upregulation of glycolysis can be opposed by the
    inhibition of hexokinase (HK), the first glycolytic enzyme. Ca2+signaling is involved
    in the NFAT activation via the Ca2+-dependent dephosphorylation by calcineurin
    (CN). A sustained Ca2+ signal is achieved due to a repression of the recycling
    of ORAI (main Ca2+ influx component) and Kv1.3 (mediating K+ efflux, which supports
    Ca2+ influx) proteins via the PI3K/SGK1 pathway (lower right). The above mechanisms
    can be opposed by inhibitors of FLT3, IL7R, γ secretase, Akt1/2, P-gp, glycolysis,
    PI3K/AKT, SGK, and mTOR as well as by BH-3 mimetics and hypomethylating agents.
    A possible toxicity of PI3R/AKT/mTOR inhibitors as well as of glycolysis/ hexokinase
    (HK) inhibitors 3-bromopyruvate (3-BP), 2-deoxy-D-glucose (2-DG), 1-(2,4-dichlorobenzyl)-1H-indazol-3
    carboxylic acid) (lonidamine, LND) needs to be considered. Some re-purposed drugs
    may improve antileukemic protocols: () TGC, which targets mitochondria and OXPHOS;
    () CBD, which targets mitochondria, causes the MTP-driven necrosis and inhibits
    P-gp; () TAM, which targets mitochondria, induces autophagy, inhibits P-gp and
    enhances the sensitivity to GCs; () anthelmintics, which inhibit GLUT1 and Hes1.
    For more details please consult the text.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOTCH2
  - NOTCH4
  - NOTCH1
  - NOTCH3
  - FLT3
  - GC
  - MYC
  - SLC2A1
  - BCL2
  - PTEN
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - MAP2K1
  - MAP2K2
  - TP53
  - TGM2
  - MTOR
  - MAPK3
  - MAPK1
  - BCL2L11
  - AKT2
  - AKT3
  - AKT1
  - FOXO3
  - FKBP5
  - HELT
  - SGK1
  - BCL2L1
  - OPN1MW
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - PAEP
  - HES1
  - CRLF2
  - NR3C1
  - TAM
  - Ca
  - leukemic
  - Leukemic
genes:
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: FLT3
  symbol: FLT3
  source: hgnc_symbol
  hgnc_symbol: FLT3
  entrez: '2322'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: FLT3
  symbol: FLT3
  source: hgnc_symbol
  hgnc_symbol: FLT3
  entrez: '2322'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: GLUT1
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK.
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK.
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: TGC
  symbol: TGC
  source: hgnc_alias_symbol
  hgnc_symbol: TGM2
  entrez: '7052'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: 'BIM:'
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Fox03a
  symbol: FOXO3A
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FKBP51
  symbol: FKBP51
  source: hgnc_alias_symbol
  hgnc_symbol: FKBP5
  entrez: '2289'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: HESI
  symbol: HESL
  source: hgnc_alias_symbol
  hgnc_symbol: HELT
  entrez: '391723'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: SGK1
  symbol: SGK1
  source: hgnc_symbol
  hgnc_symbol: SGK1
  entrez: '6446'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: BCL2L
  symbol: BCL2L
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: CBD
  symbol: CBD
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1MW
  entrez: '2652'
- word: SGK1
  symbol: SGK1
  source: hgnc_symbol
  hgnc_symbol: SGK1
  entrez: '6446'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Pep
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: FLT3
  symbol: FLT3
  source: hgnc_symbol
  hgnc_symbol: FLT3
  entrez: '2322'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: CASP1
  symbol: CASP1
  source: hgnc_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: HES1
  symbol: HES1
  source: hgnc_symbol
  hgnc_symbol: HES1
  entrez: '3280'
- word: CRLF2,
  symbol: CRLF2
  source: hgnc_symbol
  hgnc_symbol: CRLF2
  entrez: '64109'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: •GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: NR3C1
  symbol: NR3C1
  source: hgnc_symbol
  hgnc_symbol: NR3C1
  entrez: '2908'
- word: TSLPR
  symbol: TSLPR
  source: hgnc_alias_symbol
  hgnc_symbol: CRLF2
  entrez: '64109'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
chemicals:
- word: TAM
  source: MESH
  identifier: C419191
- word: Ca
  source: MESH
  identifier: D002118
diseases:
- word: leukemic
  source: MESH
  identifier: D007938
- word: Leukemic
  source: MESH
  identifier: D007938
figid_alias: PMC7991804__F2
redirect_from: /figures/PMC7991804__F2
figtype: Figure
---
